Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025
Sponsored By: Senator Cory Booker
Introduced
Summary
Expands federal research, education, and data collection on uterine fibroids to develop better, fertility-preserving treatments and to address racial disparities in outcomes. The bill would create NIH-coordinated research programs, a Medicaid/CHIP reporting effort, a public education campaign, and requirements to share evidence-based information with health care providers.
Show full summary
- Patients and families: Would push research toward minimally invasive, fertility-friendly therapies, new biomarkers, imaging, and predictive tools. Fibroids are estimated to affect about 26 million women aged 15 to 50, with roughly 15 million experiencing symptoms.
- Black individuals: Would study and aim to reduce documented disparities, including earlier onset, greater severity, and higher rates of hospitalization, hysterectomy, and myomectomy among Black patients.
- Medicaid and CHIP beneficiaries and policymakers: Would require data collection and reporting on fibroid treatment in Medicaid and the Children’s Health Insurance Program to clarify coverage, service use, and gaps in care.
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
More NIH fibroid research funding
If enacted, NIH would get $30 million per year for fiscal years 2026 through 2030 to expand and coordinate uterine fibroid research. This would fund studies on prevention, diagnosis, and treatment. The money would support research programs but would not be direct payments to patients.
Fibroid public and provider education
If enacted, the HHS Secretary would develop public information about uterine fibroids and work with medical societies and health systems to promote evidence-based care. Efforts must include outreach to minority individuals at elevated risk and cover non-hysterectomy treatment options. Congress may fund these activities each year from fiscal year 2026 through fiscal year 2030. The bill would also define "minority individuals" by cross-reference to the Public Health Service Act.
New Medicaid and CHIP fibroid data
If enacted, the HHS Secretary would set up or expand a database to track services for people with uterine fibroids in State Medicaid and CHIP plans. The Secretary would report to Congress on federal and State spending for fibroid treatment within 2 years after enactment. This would not itself change benefits or taxes.
Sponsors & CoSponsors
Sponsor
Cory Booker
NJ • D
Cosponsors
Angela Alsobrooks
MD • D
Sponsored 7/16/2025
Katie Britt
AL • R
Sponsored 7/23/2025
Roll Call Votes
No roll call votes available for this bill.
View on Congress.govTake It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in